Search - tctmd.com

Displaying 581 - 600 of 766

Sort: Relevancy | Date

News Daily News

Reducir el Uso de SLF a la Mitad en Pacientes de Bajo Riesgo podría suponer un Ahorro de 200 millones de Dólares al Año

Yael L. Maxwell

July 11, 2012

News Daily News

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Yael L. Maxwell

July 11, 2012

News Daily News

Los SLF Revelan Más Neoaterosclerosis que los SMD al cabo de 4 Años

L.A. McKeown

July 05, 2012

News Daily News

DES Show More Neoatherosclerosis Than BMS Over 4 Years

L.A. McKeown

July 05, 2012

News Daily News

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Leah Lawrence

June 15, 2012

News Industry News

STENTYS starts clinical trial to broaden portfolio with new drug-eluting stent

June 14, 2012

News Daily News

VA Registry Finds Long-term Benefit from Clopidogrel Beyond 12 Months

Caitlin E. Cox

June 11, 2012

News Industry News

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

June 04, 2012

News Daily News

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

L.A. McKeown

June 01, 2012

News Daily News

JAMA Letter: Damage to DES After Balloon Expansion Documented in All 4 FDA-Approved Devices

May 25, 2012

News Daily News

Stress Echo Appears Overused in Asymptomatic Patients after Revascularization

May 24, 2012

News Daily News

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

May 22, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Conference News EuroPCR 2012

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Caitlin E. Cox

May 18, 2012

News Conference News EuroPCR 2012

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Caitlin E. Cox

May 17, 2012

News Conference News EuroPCR 2012

CIBELES: Xience Stands Up to Cypher for CTO PCI

Caitlin E. Cox

May 17, 2012

News Conference News EuroPCR 2012

Strong Showing for Bioabsorbable-Scaffold DES

Caitlin E. Cox

May 16, 2012

News Industry News

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

May 16, 2012

News Industry News

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

May 15, 2012

News Industry News

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

May 15, 2012

Advertisement

Reducir el Uso de SLF a la Mitad en Pacientes de Bajo Riesgo podría suponer un Ahorro de 200 millones de Dólares al Año

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Los SLF Revelan Más Neoaterosclerosis que los SMD al cabo de 4 Años

DES Show More Neoatherosclerosis Than BMS Over 4 Years

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

STENTYS starts clinical trial to broaden portfolio with new drug-eluting stent

VA Registry Finds Long-term Benefit from Clopidogrel Beyond 12 Months

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

JAMA Letter: Damage to DES After Balloon Expansion Documented in All 4 FDA-Approved Devices

Stress Echo Appears Overused in Asymptomatic Patients after Revascularization

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

CIBELES: Xience Stands Up to Cypher for CTO PCI

Strong Showing for Bioabsorbable-Scaffold DES

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content